Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Change in Cash (2019 - 2026)

Strata Critical Medical (SRTA) reported Change in Cash of $27.8 million for Q1 2026, up 73.03% year-over-year from $16.0 million in Q1 2025, and up 237.82% on a QoQ basis from $8.2 million in Q4 2025.

Strata Critical Medical (SRTA) has 8 years of Change in Cash data on file, last reported at $27.8 million in Q1 2026.

  • Quarterly Change in Cash rose 73.03% year-over-year to $27.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.3 million (up 1082.25% YoY) and the FY2025 annual result came in at $11.6 million, up 223.59% from the prior year.
  • Change in Cash improved to $27.8 million in Q1 2026 per SRTA's latest filing, from $8.2 million in the prior quarter.
  • Across five years, Change in Cash topped out at $185.0 million in Q2 2022 and bottomed at -$37.3 million in Q3 2025.
  • The 5-year median for Change in Cash is -$604000.0 (2023), against an average of $13.4 million.
  • Peak annual rise in Change in Cash reached 1596.52% in 2024, while the deepest fall reached 521.98% in 2024.
  • Tracing SRTA's Change in Cash over 5 years: stood at $185.0 million in 2022, then slumped by 105.0% to -$9.3 million in 2023, then jumped by 80.99% to -$1.8 million in 2024, then soared by 567.08% to $8.2 million in 2025, then surged by 237.82% to $27.8 million in 2026.
  • Per Business Quant, the three latest SRTA Change in Cash figures stand at $27.8 million (Q1 2026), $8.2 million (Q4 2025), and -$37.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -100.00 Mn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 84.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn -31.34 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 60.50 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn 35.62 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn -18.77 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 399.14 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn -57.66 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn 41.66 Mn
10 Strata Critical Medical 538.39 Mn 479.60 Mn 14.12 Mn 27.76 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 27.76 Mn
Dec 31, 2025 8.22 Mn
Sep 30, 2025 -37.30 Mn
Jun 30, 2025 24.63 Mn
Mar 31, 2025 16.04 Mn
Dec 31, 2024 -1.76 Mn
Sep 30, 2024 -6.96 Mn
Jun 30, 2024 -9.69 Mn
Mar 31, 2024 9.04 Mn
Dec 31, 2023 -9.25 Mn
Sep 30, 2023 -1.12 Mn
Jun 30, 2023 -4.43 Mn
Mar 31, 2023 -604,000.00
Jun 30, 2022 185.02 Mn
Mar 31, 2022 951,000.00
Sep 30, 2021 -2.76 Mn
Jun 30, 2021 18.36 Mn
Mar 31, 2021 -2.41 Mn
Sep 30, 2020 -416,060.00
Jun 30, 2020 -288,130.00
Mar 31, 2020 -212,273.00
Dec 31, 2019 1.31 Mn
Sep 30, 2019 1.82 Mn